Treatment of intracranial arterial stenosis

Expert Review of Neurotherapeutics

Volumn 6, Issue 11, 2006, Pages 1685-1694

  Taylor, Robert A ^b   Kasner, Scott E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Angioplasty; Aspirin; Intracranial stenosis; Intracranial stenting; Warfarin

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; PLACEBO; PLATELET GLYCOPROTEIN 2B INHIBITOR; PLATELET GLYCOPROTEIN 3A INHIBITOR; PRAVASTATIN; ROSUVASTATIN; WARFARIN;

ANGIOPLASTY; ARTERY OCCLUSION; ARTERY RUPTURE; ATHEROSCLEROTIC PLAQUE; BALLOON DILATATION; BLEEDING; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN DEATH; BRAIN HEMORRHAGE; BYPASS SURGERY; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DEVICE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MONOTHERAPY; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKULL SURGERY; STENT; STROKE; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

ANGIOPLASTY; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; STENTS;

EID: 33845393722     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.11.1685     Document Type: Review

References (41)

1. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 7(11), 1974-1980 (1996).
2. Feldmann E, Daneault N, Kwan E et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology 40(10), 1541-1545 (1990).
3. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26(1), 14-20 (1995).
4. Chimowitz MI. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch. Neurol. 58(10), 1690-1692 (2001).
5. Gomez CR, Orr SC. Angioplasty and stenting for primary treatment of intracranial arterial stenoses. Arch. Neurol. 58(10), 1687-1690 (2001).
6. The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35(6), 1388-1392 (2004).
7. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 22(2), 106-117 (2003).
8. Chimowitz MI, Kokkinos J, Strong J et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology 45(8), 1488-1493 (1995).
9. Millikan CH, Siekert RG, Shick RM. Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Mayo Clin. Proc. 30, 116-216 (1955).
10. Mohr JP, Thompson JLP, Lazar RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 345, 1444-1451 (2001).
11. Benesch CG, Chimowitz MI. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology 55(4), 465-466 (2000).
12. Chimowitz MI, Lynn MJ, Howlett-Smith H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 352(13), 1305-1316 (2005). •• Randomized, controlled trial that has had the greatest impact on the medical management of intracranial stenosis.
13. Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin vs. aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID. Neurology 67(7), 1275-1278 (2006).
14. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol. Sci. 143(1-2), 1-13 (1996).
15. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038), 1329-1339 (1996).
16. Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113(4), 555-563 (2006). •• This subgroup analysis of the WASID trial identifies patients with intracranial stenosis at highest risk for recurrent stroke.
17. Kwon SU, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36(4), 782-786 (2005).
18. Amarenco P, Bogousslavsky J, Callahan A 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355(6), 549-559 (2006).
19. Schoenhagen P, Tuzcu EM, Apperson-Hansen C et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 113(24), 2826-2834 (2006).
20. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295(13), 1556-1565 (2006).
21. Sundt TM Jr, Siekert RG, Piepgras DG, Sharbrough FW, Houser OW. Bypass surgery for vascular disease of the carotid system. Mayo Clin. Proc. 51(11), 677-6792 (1976).
22. The EC-IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N. Engl. J. Med. 313, 1191-1200 (1985).
23. Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc. 55(11), 673-680 (1980).
24. O'Leary DH, Clouse ME. Percutaneous transluminal angioplasty of the cavernous carotid artery for recurrent ischemia. Am. J. Neuroradiol. 5(5), 644-645 (1984).
25. Chaloupka JC, Weigele JB, Mangla S, Lesley WS. Cerebrovascular angioplasty and stenting for the prevention of stroke. Curr. Neurol. Neurosci. Rep. 1(1), 39-53 (2001). • Review article with a thorough section summarizing early data on intracranial angioplasty and stenting until the year 2000.
26. Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J. Neurosurg. 91(3), 415-423 (1999).
27. Marks MP, Wojak JC, Al-Ali F et al. Angioplasty for symptomatic intracranial stenosis. Clinical Outcome. Stroke 37(4), 1016-1020 (2006).
28. Gomez CR, Misra VK, Liu MW et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 31(1), 95-99 (2000).
29. Kim DJ, Lee BH, Kim DI, Shim WH, Jeon P, Lee TH. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. Am. J. Neuroradiol. 26(6), 1381-1388 (2005).
30. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. Am. J. Neuroradiol. 26(4), 869-874 (2005).
31. Weber W, Mayer TE, Henkes H et al. Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur. J. Radiol. 55(2), 231-236 (2005).
32. Jiang WJ, Wang YJ, Du B et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 35(6), 1375-1380 (2004).
33. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 36(12), E165-E168 (2005).
34. Lee TH, Kim DH, Lee BH et al. Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. Am. J. Neuroradiol. 26(1), 166-174 (2005).
35. Yan BP, Clark DJ, Ajani AE. Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opin. Pharmacother. 6(1), 3-12 (2005).
36. Jaeger HJ, Mathias KD, Drescher R et al. Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. Am. J. Neuroradiol. 22(7), 1251-1259 (2001).
37. Alberts MJ, Hademenos G, Latchaw RE et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 283(23), 3102-3109 (2000).
38. Levy EI, Horowitz MB, Koebbe CJ et al. Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 48(6), 1215-1221 (2001).
39. Kim JK, Ahn JY, Lee BH et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J. Neurol. Neurosurg. Psychiatry 75(6), 847-851 (2004).
40. US Food and Drug Adminisration www.fda.gov/cdrh/pdf/h010004b.pdf
41. US Food and Drug Administration www.fda.gov/cdrh/pdf5/h050001b.pdf